Drug makers Moderna and Pfizer announced this week that early test results show their respective COVID-19 vaccines to be more than 90% effective. Now, both are on track to request emergency authorization from the FDA. But even as scientists race to roll out a vaccine, there are questions about the diversity of the test subjects. Soledad O’Brien speaks with Dr. James E. K. Hildreth, one of the nation’s leading immunologists and head of the Meharry Medical College in Nashville.
Wildlife Veterinarian Discusses Impacts of Bird Flu
June 16, 2024Wildlife Veterinarian Discusses Impacts of Bird Flu
June 16, 2024
JUNE 15, 2024
June 16, 2024JUNE 15, 2024
June 16, 2024
Wastewater Testing Becomes Useful Tool for Community Health
March 3, 2024Wastewater Testing Becomes Useful Tool for Community Health
March 3, 2024
MARCH 2, 2024
March 3, 2024MARCH 2, 2024
March 3, 2024
End of the Pandemic or The Start of Something Else?
January 16, 2022End of the Pandemic or The Start of Something Else?
January 16, 2022
How West Virginia Went From First to the Bottom in Vaccination Rates
December 5, 2021How West Virginia Went From First to the Bottom in Vaccination Rates
December 5, 2021
How the Pandemic Could Erase Decades of Progress for Women in the Workforce
November 14, 2021How the Pandemic Could Erase Decades of Progress for Women in the Workforce
November 14, 2021
COVID Patients are Checking Out, But Hospitals are Still Overwhelmed
November 7, 2021COVID Patients are Checking Out, But Hospitals are Still Overwhelmed
November 7, 2021
